Skip to main content

Table 2 Association of variables with anti-HCV positivity among patients on hemodialysis in December 2015 in Kosovo, as determined by univariate and multivariate logistic regression analysis

From: A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study

Explanatory variable

n

%

Anti-HCV positive (%)

Unadjusted PR

CI 95%

p-value

Adjusted PR

CI 95%

p-value

Sex

         

 Female

299

48.4

42.8

ref (1)

 

0.498

ref (1)

 

0.480

 Male

319

51.6

36.4

0.955

0.836–1.910

 

0.978

0.818–1.170

 

Age (years)

Mean ± SD

56.3 ± 12.7

   

0.985

0.972–0.998

0.021*

0.997

0.992–1.003

0.327

Age (years)

         

  ≤ 39

52

8.4

51.9

      

 40–49

96

15.5

41.7

 50–59

178

28.8

40.4

 60–69

180

29.1

38.9

  ≥ 70

112

18.1

31.3

Duration of dialysis (years)

Mean ± SD

8.8 ± 5.7

   

1.032

1.020–1.044

<  0.0001*

1.032

1.017–1.042

<  0.0001*

Duration of dialysis (years)

         

  ≥ 20

11

1.8

90.9

      

 10–19

83

13.4

83.1

  ≤ 9

520

84.1

31.5

 Missing

4

0.7

 

Hemodialysis at regional dialysis center

         

 Center 1

167

27.0

18.0

ref (1)

 

0.060

ref (1)

 

0.065

 Center 2

63

10.2

69.8

1.440

1.138–1.822

 

1.436

1.135–1.817

 

 Center 3

78

12.6

33.3

1.130

0.891–1.433

1.134

0.894–1.439

 Center 4

153

24.8

50.3

1.274

1.054–1.541

1.271

1.051–1.537

 Center 5

45

7.3

35.6

1.149

0.862–1.531

1.163

0.871–1.552

 Center 6

48

7.8

35.4

1.148

0.867–1.519

1.151

0.870–1.524

 Center 7

64

10.4

53.1

1.298

1.019–1.654

1.302

1.022–1.659

Hemodialysis at more than one center

         

 No

240

38.8

20.8

ref (1)

 

0.002*

ref (1)

 

0.026*

 Yes

378

61.2

51.3

1.251

1.086–1.442

 

1.180

1.020–1.365

 

Blood transfusion

         

 No

142

23.0

21.8

ref (1)

 

0.043*

ref (1)

 

0.341

 Yes

476

77.0

44.7

1.188

1.006–1.404

 

0.92

0.817–1.041

 
  1. SD standard deviation, PR unadjusted prevalence ratio, APR adjusted prevalence ratio; *p < 0.05; p (Wald test)